The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
SINOVAC BIOTECH LTD | SHS | P8696W104 | 405,359 | 10,780,820 | SH | SOLE | 10,780,820 | 0 | 0 | ||
HUIZE HLDG LTD | SPONSORED ADS | 44473E105 | 56,398 | 6,738,124 | SH | SOLE | 6,738,124 | 0 | 0 | ||
Q&K INTL GROUP LTD | SPONSORED ADS | 74738J102 | 10,400 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 |